Synergy CHC Corp. Receives Nasdaq Delisting Notice for Minimum Bid Price Violation
SNYR is trading near its 52-week low of $0.27 (6.0% above the low) on light trading volume (0.4× avg).
Summary
Synergy CHC Corp. received a Nasdaq delisting notice for failing to maintain the minimum $1.00 bid price, initiating a 180-day compliance period to avoid delisting.
Key Events · Legal and Risk Events · SNYR
-
Nasdaq Delisting Notice Received
On May 15, 2026, Synergy CHC Corp. received a notice from Nasdaq for non-compliance with the minimum bid price requirement.
-
Minimum Bid Price Violation
The company's common stock failed to maintain a closing bid price of $1.00 or more for 30 consecutive business days.
-
180-Day Compliance Period
Synergy CHC Corp. has an initial 180-calendar-day period, until November 11, 2026, to regain compliance.
-
Risk of Delisting
Failure to regain compliance could result in the delisting of the company's common stock from The Nasdaq Capital Market.
Analysis · SNYR · Life Sciences
Synergy CHC Corp. received a formal notice from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement. This is a critical development, as continued non-compliance could lead to the delisting of its common stock from the Nasdaq Capital Market. The company has 180 calendar days, until November 11, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. This notice adds to a series of recent negative events, including significant net losses, material weaknesses, highly dilutive financing activities, and an informal default allegation, highlighting severe financial distress and increasing the risk for investors.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SNYR was trading at $0.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $0.27 to $4.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.